These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22451420)

  • 1. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.
    Guo H; Ma O; Speck NA; Friedman AD
    Blood; 2012 May; 119(19):4408-18. PubMed ID: 22451420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
    Cooper S; Guo H; Friedman AD
    PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
    Guo H; Cooper S; Friedman AD
    PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HoxA9 binds and represses the Cebpa +8 kb enhancer.
    Peng L; Guo H; Ma P; Sun Y; Dennison L; Aplan PD; Hess JL; Friedman AD
    PLoS One; 2019; 14(5):e0217604. PubMed ID: 31120998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulopoiesis requires increased C/EBPα compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells.
    Ma O; Hong S; Guo H; Ghiaur G; Friedman AD
    PLoS One; 2014; 9(4):e95784. PubMed ID: 24752325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C/EBPα induces Ebf1 gene expression in common lymphoid progenitors.
    Barberi T; Cui C; Friedman AD
    PLoS One; 2020; 15(12):e0244161. PubMed ID: 33332417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPα in normal and malignant myelopoiesis.
    Friedman AD
    Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cebpa +37-kb enhancer directs transgene expression to myeloid progenitors and to long-term hematopoietic stem cells.
    Guo H; Ma O; Friedman AD
    J Leukoc Biol; 2014 Sep; 96(3):419-26. PubMed ID: 24868087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.
    Simeoni F; Romero-Camarero I; Camera F; Amaral FMR; Sinclair OJ; Papachristou EK; Spencer GJ; Lie-A-Ling M; Lacaud G; Wiseman DH; Carroll JS; Somervaille TCP
    Cell Rep; 2021 Sep; 36(12):109725. PubMed ID: 34551306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment.
    Yeamans C; Wang D; Paz-Priel I; Torbett BE; Tenen DG; Friedman AD
    Blood; 2007 Nov; 110(9):3136-42. PubMed ID: 17671233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
    Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
    Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Runx1 Phosphorylation by Src Increases Trans-activation via Augmented Stability, Reduced Histone Deacetylase (HDAC) Binding, and Increased DNA Affinity, and Activated Runx1 Favors Granulopoiesis.
    Leong WY; Guo H; Ma O; Huang H; Cantor AB; Friedman AD
    J Biol Chem; 2016 Jan; 291(2):826-36. PubMed ID: 26598521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHP2 tyrosine phosphatase stimulates CEBPA gene expression to mediate cytokine-dependent granulopoiesis.
    Zhang L; Friedman AD
    Blood; 2011 Aug; 118(8):2266-74. PubMed ID: 21725048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of CCAAT/Enhancer Binding Protein (C/EBP) Alpha (CEBPA) and Runt-Related Transcription Factor 1 (RUNX1) Expression in Patients with De Novo Acute Myeloid Leukemia.
    Salarpour F; Goudarzipour K; Mohammadi MH; Ahmadzadeh A; Faraahi S; Farsani MA
    Ann Hum Genet; 2017 Nov; 81(6):276-283. PubMed ID: 28895127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein alpha function.
    Tokita K; Maki K; Mitani K
    Cancer Sci; 2007 Nov; 98(11):1752-7. PubMed ID: 17894555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.
    Ptasinska A; Pickin A; Assi SA; Chin PS; Ames L; Avellino R; Gröschel S; Delwel R; Cockerill PN; Osborne CS; Bonifer C
    Cell Rep; 2019 Sep; 28(12):3022-3031.e7. PubMed ID: 31533028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
    Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 cases.
    Fasan A; Alpermann T; Haferlach C; Grossmann V; Roller A; Kohlmann A; Eder C; Kern W; Haferlach T; Schnittger S
    PLoS One; 2013; 8(2):e54365. PubMed ID: 23383300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs.
    Gerritsen M; Yi G; Tijchon E; Kuster J; Schuringa JJ; Martens JHA; Vellenga E
    Blood Adv; 2019 Feb; 3(3):320-332. PubMed ID: 30709863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha.
    Friedman AD; Keefer JR; Kummalue T; Liu H; Wang QF; Cleaves R
    Blood Cells Mol Dis; 2003; 31(3):338-41. PubMed ID: 14636649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.